ClinicalTrials.Veeva

Menu

Beneficial Effects of Natural Products on Management of Xerostomia

B

British University In Egypt

Status

Completed

Conditions

Post COVID-19 Condition
Hypertension
Xerostomia
Diabetes Mellitus

Treatments

Other: (Manuka honey-green tea)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Xerostomia, the subjective feeling of oral dryness, is a symptom most frequently accompanied by either decreased salivary flow or an altered composition of saliva. Hyposalivation, on the other hand, is the objective measured reduction in salivary flow rate. Xerostomia is a relatively common complaint, particularly among older people, and can lead to major consequences with regard to the quality of their general and oral health and wellbeing.

Xerostomia has a variety of possible etiological factors; it is generally classified as having primary and secondary causes. Primary causes comprise conditions that directly affect the salivary glands and induce xerostomia like, Sjogren's syndrome, diabetes mellitus type 1 and 2, thyroid disease, adrenal pathology, renal or hepatic diseases, hepatitis C virus infection, and HIV disease.

Full description

Multiple pharmacological and non-pharmacological measures that have been tested in previous studies in order to improve xerostomia in patients suffering from that complaint which were based on the stimulation of the salivary gland flow. Salivary glands can be stimulated to produce saliva mechanically (for example, by chewing gum, using different formulated mouthwashes or acupressure) or through medications (such as pilocarpine, cevimeline, angiotensin-converting enzyme inhibitors and angiotensin-receptor antagonists) Overall, the available interventions do not appear to provide an effective, comprehensive and long-term management of xerostomia. This has strengthened the need for further investigation of other interventions for the management of xerostomia As Egypt is considered a low-income country, therefore, the general properties of ideal saliva substitutes to be used should be inexpensive, edible, hydrating, safe-to-swallow but retainable in the mouth.

Given the importance of the oral health status of in patients suffering from dry mouth with the associated problems, and the limited availability of proper remedy for xerostomia in the Egyptian market. This study is designed to evaluate the efficiency of different and natural treatment as a mix of (Manuka honey -green tea) mouth rinse in management of xerostomia.

Enrollment

28 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    • Both genders, aged above 19 years.
  • All patients must have complaint of xerostomia.
  • Objective dry mouth score from (2-5).
  • Subjective dry mouth score from (1-4).
  • Patients must be able to make reliable decision or communications.

Exclusion criteria

    • Smoking, Alcohol.
  • Patient with history of any serious illness as malignancy.
  • Patients with any autoimmune disease.
  • Vulnerable groups such as pregnant females, prisoners, mentally and physically handicapped individuals.
  • Known hypersensitivity or severe adverse effects to the treatment drugs or to any ingredient of their preparation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

28 participants in 2 patient groups, including a placebo group

(Manuka honey-green tea) interventional arm
Active Comparator group
Description:
• (Manuka honey-green tea) will topically be applied to the oral mucosa as oral rinse 3 times per day to treat xerostomia.
Treatment:
Other: (Manuka honey-green tea)
Saline mouthwash control group
Placebo Comparator group
Description:
Patients in the control arm followed the same protocol with normal saline rinses in the same bottles 3 times per day for xerostomia
Treatment:
Other: (Manuka honey-green tea)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems